A Case of High Dose Cytosine Arabinoside Induced Stevens-Johnson Syndrome in a Patient with Malignant Lymphoma / 대한혈액학회지
Korean Journal of Hematology
;
: 292-295, 2007.
Article
in Korean
| WPRIM
| ID: wpr-721002
ABSTRACT
Many chemotherapeutic agents induce variable cutaneous adverse reactions. Among the side effects, Stevens-Johnson syndrome is rare, but a fatal complication. There are two prior reports of cytosine arabinoside (ARA-C) induced toxic epidermal necrolysis, which is considered in the continuum of Stevens- Johnson syndrome. The prior cases were female patients under 16 years old with acute lymphocytic leukemia. We treated a 77-year-old man with recurrent mantle cell lymphoma who developed Stevens- Johnson syndrome after high dose ARA-C therapy. This is the first case of ARA-C induced Stevens- Johnson syndrome in Korea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Stevens-Johnson Syndrome
/
Lymphoma, Mantle-Cell
/
Cytarabine
/
Cytosine
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Korea
/
Lymphoma
Limits:
Adolescent
/
Aged
/
Female
/
Humans
Country/Region as subject:
Asia
Language:
Korean
Journal:
Korean Journal of Hematology
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS